Brief: Ceapro Reports Preliminary Results From Trial Evaluating High Cholesterol Treatment
17/11/2021 12:12
Nov 17 (Reuters) - Ceapro Inc CZO.V :
* CEAPRO INC. REPORTS PRELIMINARY RESULTS FROM CLINICAL
TRIAL
EVALUATING OAT BETA GLUCAN IN PATIENTS WITH HIGH CHOLESTEROL
LEVELS
* CEAPRO INC - FROM A SAFETY PERSPECTIVE, THERE WAS NO DEATH
AND
BETA GLUCAN WAS GENERALLY WELL TOLERATED
* CEAPRO INC - OVERALL COMPLIANCE TO STUDY PILL INTAKE WAS
GREATER
THAN 80%
Source text for Eikon: ID:nGNXPyys1
Further company coverage: CZO.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ceapro
See all newsBrief: Aeterna Zentaris Announces Details Regarding Transaction with Ceapro
Brief: Ceapro Receives Final Court Approval For Merger With Aeterna Zentaris
Brief: Aeterna Zentaris And Ceapro Announce Merger Of Equals To Create Diversified Biopharmaceutical Company
Brief: Ceapro Inc. Reports 2023 Third Quarter And Nine-Month Financial Results And Operational Highlights
Brief: Ceapro Initiates Phase 1-2A Study Assessing Avenanthramides For Potential Applications In Inflammation Based Diseases